This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

10 Jun 2011

Celerion Sites Certified for Brazilian Market

Celerion's several facilities have been approved by the Brazilian regulators to enter the Brazilian market.

Celerion, a provider of innovative early stage drug development solutions, has announced that its clinical research operations in Belfast, Northern Ireland, and its clinical research and bioanalytical services operations in Lincoln, NE, have been certified by the Brazilian National Health Surveillance Agency (ANVISA).


ANVISA provides regulatory approval for drugs and other products seeking to enter the Brazilian market.


"The approval of ANVISA continues to demonstrate the high quality work done at Celerion,” said Susan Thornton, president and chief executive officer. “By earning ANVISA certification to conduct early clinical studies and bioanalytical research for compounds destined for Brazil, Celerion is now able to better serve our clients’ growing need

Related News